Role of Oral Factor Xa Inhibitors after Acute Coronary Syndrome

Publisher： Karger

E-ISSN： 1421-9751|129|4|224-232

ISSN： 0008-6312

Source： Cardiology, Vol.129, Iss.4, 2014-11, pp. : 224-232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is there Evidence to Support the Use of Direct Factor Xa Inhibitors in Coronary Artery Disease?

By  

Reviews on Recent Clinical Trials, Vol. 6, Iss. 2, 2011-05 ,pp. : 147-157

Bentham Science Publishers

Access to resources Recommend Favorite

Reversal of oral factor Xa inhibitors by prothrombin complex concentrates: a re‐appraisal

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. S1, 2015-06 ,pp. : S187-S194

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral Factor Xa Inhibitors for Venous Thromboembolism Prevention in Major Orthopedic Surgery: A Review

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 36, Iss. 5, 2009-12 ,pp. : 217-226

Karger

Access to resources Recommend Favorite

Oral, direct Factor Xa inhibition with BAY 59‐7939 for the prevention of venous thromboembolism after total hip replacement

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 121-128

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Psychosocial Context Impacts Medication Adherence After Acute Coronary Syndrome

By Kronish Ian   Rieckmann Nina   Burg Matthew   Alcántara Carmela   Davidson Karina  

Annals of Behavioral Medicine, Vol. 47, Iss. 2, 2014-04 ,pp. : 158-164

Springer Publishing Company

Access to resources Recommend Favorite